Constantine A Gatsonis
Overview
Explore the profile of Constantine A Gatsonis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
5502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Korevaar D, Hooft L, Askie L, Barbour V, Faure H, Gatsonis C, et al.
Clin Chem
. 2017 Jun;
63(8):1331-1341.
PMID: 28630237
No abstract available.
12.
Cohen J, Korevaar D, Altman D, Bruns D, Gatsonis C, Hooft L, et al.
BMJ Open
. 2017 Feb;
6(11):e012799.
PMID: 28137831
Diagnostic accuracy studies are, like other clinical studies, at risk of bias due to shortcomings in design and conduct, and the results of a diagnostic accuracy study may not apply...
13.
Bolan P, Kim E, Herman B, Newstead G, Rosen M, Schnall M, et al.
J Magn Reson Imaging
. 2016 Dec;
46(1):290-302.
PMID: 27981651
Purpose: To estimate the accuracy of predicting response to neoadjuvant chemotherapy (NACT) in patients with locally advanced breast cancer using MR spectroscopy (MRS) measurements made very early in treatment. Materials...
14.
Bossuyt P, Cohen J, Gatsonis C, Korevaar D
Ann Transl Med
. 2016 Mar;
4(4):85.
PMID: 27004232
No abstract available.
15.
Hylton N, Gatsonis C, Rosen M, Lehman C, Newitt D, Partridge S, et al.
Radiology
. 2015 Dec;
279(1):44-55.
PMID: 26624971
Purpose: To evaluate volumetric magnetic resonance (MR) imaging for predicting recurrence-free survival (RFS) after neoadjuvant chemotherapy (NACT) of breast cancer and to consider its predictive performance relative to pathologic complete...
16.
Bossuyt P, Reitsma J, Bruns D, Gatsonis C, Glasziou P, Irwig L, et al.
BMJ
. 2015 Oct;
351:h5527.
PMID: 26511519
No abstract available.
17.
Bossuyt P, Reitsma J, Bruns D, Gatsonis C, Glasziou P, Irwig L, et al.
Clin Chem
. 2015 Oct;
61(12):1446-52.
PMID: 26510957
Incomplete reporting has been identified as a major source of avoidable waste in biomedical research. Essential information is often not provided in study reports, impeding the identification, critical appraisal, and...
18.
Bossuyt P, Reitsma J, Bruns D, Gatsonis C, Glasziou P, Irwig L, et al.
Radiology
. 2015 Oct;
277(3):826-32.
PMID: 26509226
Incomplete reporting has been identified as a major source of avoidable waste in biomedical research. Essential information is often not provided in study reports, impeding the identification, critical appraisal, and...
19.
Weber W, Gatsonis C, Mozley P, Hanna L, Shields A, Aberle D, et al.
J Nucl Med
. 2015 Apr;
56(8):1137-43.
PMID: 25908829
Unlabelled: PET/CT with the glucose analog (18)F-FDG has several potential applications for monitoring tumor response to therapy in patients with non-small cell lung cancer (NSCLC). A prerequisite for many of...
20.
Mahler S, Miller C, Litt H, Gatsonis C, Snyder B, Hollander J
Acad Emerg Med
. 2015 Mar;
22(4):452-60.
PMID: 25810343
Objectives: The 2-hour accelerated diagnostic protocol (ADAPT) is a decision rule designed to identify emergency department (ED) patients with chest pain for early discharge. Previous studies in the Asia-Pacific region...